Sharon Elad

Summary

Affiliation: The Hebrew University
Country: Israel

Publications

  1. doi request reprint Topical immunomodulators for management of oral mucosal conditions, a systematic review; part I: calcineurin inhibitors
    Sharon Elad
    Hebrew University Hadassah School of Dental Medicine, Department of Oral Medicine, POB 12272, Jerusalem 91120, Israel
    Expert Opin Emerg Drugs 15:713-26. 2010
  2. doi request reprint Topical immunomodulators for management of oral mucosal conditions, a systematic review; Part II: miscellaneous agents
    Sharon Elad
    Hebrew University Hadassah School of Dental Medicine, Department of Oral Medicine, POB 12272, Jerusalem 91120, Israel
    Expert Opin Emerg Drugs 16:183-202. 2011
  3. doi request reprint Validation of the National Institutes of Health (NIH) scale for oral chronic graft-versus-host disease (cGVHD)
    Sharon Elad
    Department of Oral Medicine, Hebrew University, Hadassah School of Dental Medicine, Jerusalem, Israel
    Biol Blood Marrow Transplant 16:62-9. 2010
  4. doi request reprint A randomized controlled trial of visible-light therapy for the prevention of oral mucositis
    Sharon Elad
    Department of Oral Medicine, Hebrew University Hadassah School of Dental Medicine, Jerusalem, Israel
    Oral Oncol 47:125-30. 2011
  5. doi request reprint Dental treatment for high-risk patients with refractory heart failure: a retrospective observational comparison study
    Mordechai Findler
    Department of Hospital Oral Medicine, Hebrew University Hadassah School of Dental Medicine, Jerusalem, Israel
    Quintessence Int 44:61-70. 2013
  6. doi request reprint Improvement in oral chronic graft-versus-host disease with the administration of effervescent tablets of topical budesonide-an open, randomized, multicenter study
    Sharon Elad
    Department of Oral Medicine, Hebrew University Hadassah School of Dental Medicine, Jerusalem, Israel
    Biol Blood Marrow Transplant 18:134-40. 2012
  7. ncbi request reprint The antimicrobial effect of Iseganan HCl oral solution in patients receiving stomatotoxic chemotherapy: analysis from a multicenter, double-blind, placebo-controlled, randomized, phase III clinical trial
    Sharon Elad
    Department of Oral Medicine, Hebrew University Hadassah School of Dental Medicine, Jerusalem, Israel
    J Oral Pathol Med 41:229-34. 2012
  8. ncbi request reprint Survey of acceptance of the 2007 American Heart Association guidelines for the prevention of infective endocarditis: a pilot study
    Sharon Elad
    Department of Oral Medicine, Hadassah School of Dental Medicine, Hebrew University, Jerusalem, Israel
    Quintessence Int 42:243-51. 2011
  9. ncbi request reprint Budesonide: a novel treatment for oral chronic graft versus host disease
    Sharon Elad
    Hospital Oral Medicine Department, Hadassah University Hospital and The Hebrew University Hadassah School Of Dental Medicine, Jerusalem, Israel
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod 95:308-11. 2003
  10. ncbi request reprint Oral posttransplantation lymphoproliferative disorder: an uncommon site for an uncommon disorder
    Sharon Elad
    Department of Oral Medicine, Hebrew University Hadassah School of Dental Medicine, Jerusalem, Israel
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod 105:59-64. 2008

Detail Information

Publications25

  1. doi request reprint Topical immunomodulators for management of oral mucosal conditions, a systematic review; part I: calcineurin inhibitors
    Sharon Elad
    Hebrew University Hadassah School of Dental Medicine, Department of Oral Medicine, POB 12272, Jerusalem 91120, Israel
    Expert Opin Emerg Drugs 15:713-26. 2010
    ....
  2. doi request reprint Topical immunomodulators for management of oral mucosal conditions, a systematic review; Part II: miscellaneous agents
    Sharon Elad
    Hebrew University Hadassah School of Dental Medicine, Department of Oral Medicine, POB 12272, Jerusalem 91120, Israel
    Expert Opin Emerg Drugs 16:183-202. 2011
    ....
  3. doi request reprint Validation of the National Institutes of Health (NIH) scale for oral chronic graft-versus-host disease (cGVHD)
    Sharon Elad
    Department of Oral Medicine, Hebrew University, Hadassah School of Dental Medicine, Jerusalem, Israel
    Biol Blood Marrow Transplant 16:62-9. 2010
    ..Analysis of categoric parameters suggests that the NIH scale disproportionately differentiates between moderate-erythema/ulceration and severe-lichenoid cGVHD...
  4. doi request reprint A randomized controlled trial of visible-light therapy for the prevention of oral mucositis
    Sharon Elad
    Department of Oral Medicine, Hebrew University Hadassah School of Dental Medicine, Jerusalem, Israel
    Oral Oncol 47:125-30. 2011
    ..These findings suggest that the VLT-device is safe and effective for the prevention of oral mucositis in patients undergoing HSCT...
  5. doi request reprint Dental treatment for high-risk patients with refractory heart failure: a retrospective observational comparison study
    Mordechai Findler
    Department of Hospital Oral Medicine, Hebrew University Hadassah School of Dental Medicine, Jerusalem, Israel
    Quintessence Int 44:61-70. 2013
    ..The changes have significant implications for the medical management of the disease, as well as on the ability to provide proper dental treatment for these patients...
  6. doi request reprint Improvement in oral chronic graft-versus-host disease with the administration of effervescent tablets of topical budesonide-an open, randomized, multicenter study
    Sharon Elad
    Department of Oral Medicine, Hebrew University Hadassah School of Dental Medicine, Jerusalem, Israel
    Biol Blood Marrow Transplant 18:134-40. 2012
    ..The response was similar in all treatment arms. Safety analysis supported a dosing schedule of 3 mg of budesonide 3 times a day for 10 minutes...
  7. ncbi request reprint The antimicrobial effect of Iseganan HCl oral solution in patients receiving stomatotoxic chemotherapy: analysis from a multicenter, double-blind, placebo-controlled, randomized, phase III clinical trial
    Sharon Elad
    Department of Oral Medicine, Hebrew University Hadassah School of Dental Medicine, Jerusalem, Israel
    J Oral Pathol Med 41:229-34. 2012
    ..These complications prompted us to assess the antimicrobial activity of a topical Iseganan HCl mouthwash vs. placebo on the aerobic and facultatively anaerobic oral flora in these patients...
  8. ncbi request reprint Survey of acceptance of the 2007 American Heart Association guidelines for the prevention of infective endocarditis: a pilot study
    Sharon Elad
    Department of Oral Medicine, Hadassah School of Dental Medicine, Hebrew University, Jerusalem, Israel
    Quintessence Int 42:243-51. 2011
    ..To evaluate the acceptance rate of the 2007 American Heart Association (AHA) prophylactic protocol by the patients for whom the need for prophylaxis for infective endocarditis was downgraded...
  9. ncbi request reprint Budesonide: a novel treatment for oral chronic graft versus host disease
    Sharon Elad
    Hospital Oral Medicine Department, Hadassah University Hospital and The Hebrew University Hadassah School Of Dental Medicine, Jerusalem, Israel
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod 95:308-11. 2003
    ..This clinical trial aims to evaluate the efficacy of budesonide, a newly registered steroid with high potency and low bioavailability, for the treatment of chronic oral graft versus host disease (GVHD)...
  10. ncbi request reprint Oral posttransplantation lymphoproliferative disorder: an uncommon site for an uncommon disorder
    Sharon Elad
    Department of Oral Medicine, Hebrew University Hadassah School of Dental Medicine, Jerusalem, Israel
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod 105:59-64. 2008
    ..Because oral PTLD is of clinical relevance to oral health providers, the importance of distinguishing between PTLD and nontransplantation related lymphoma is outlined, and the clinical implications of oral PTLD are discussed...
  11. ncbi request reprint Time limitations and the challenge of providing infection-preventing dental care to hematopoietic stem-cell transplantation patients
    Sharon Elad
    Oral Medicine Department, The Hebrew University Hadassah School of Dental Medicine, Hadassah University Hospital, POB 12000, 91120, Jerusalem, Israel
    Support Care Cancer 11:674-7. 2003
    ..This study aims to shed light on the challenges facing hospital dentists in the implementation of optimal oral-dental treatment prior to HSCT...
  12. ncbi request reprint Saliva secretion in patients with allergic rhinitis
    Sharon Elad
    Oral Medicine Department and School of Dental Medicine, the Hebrew University Hadassah, Jerusalem, Israel
    Int Arch Allergy Immunol 141:276-80. 2006
    ..This study aimed to examine the effect of loratadine and fexofenadine on the salivary gland function in patients diagnosed with allergic rhinitis compared to untreated allergic patients and healthy individuals...
  13. doi request reprint The cardiovascular effect of local anesthesia with articaine plus 1:200,000 adrenalin versus lidocaine plus 1:100,000 adrenalin in medically compromised cardiac patients: a prospective, randomized, double blinded study
    Sharon Elad
    Oral Medicine Service, Hadassah University Hospital, Department of Oral Medicine, Hebrew University Hadassah School of Dental Medicine, Jerusalem, Israel
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod 105:725-30. 2008
    ..This study compared cardiovascular safety profiles of 2 local anesthetics (LA): articaine (Ubistesine) versus standard lidocaine solution in cardiovascular patients...
  14. doi request reprint A critically severe gingival bleeding following non-surgical periodontal treatment in patients medicated with anti-platelet
    Sharon Elad
    Department of Oral Medicine, Hebrew University Hadassah School of Dental Medicine, Jerusalem, Israel
    J Clin Periodontol 35:342-5. 2008
    ..Only a few dental procedures have been reported to cause life-threatening bleeding. All of these cases followed surgical intervention...
  15. ncbi request reprint A decision analysis: the dental management of patients prior to hematology cytotoxic therapy or hematopoietic stem cell transplantation
    Sharon Elad
    Department of Oral Medicine, The Hebrew University Hadassah School of Dental Medicine, POB 12272, Jerusalem 91120, Israel
    Oral Oncol 44:37-42. 2008
    ..Using our base case data, 1.8 of every 1000 hemato-oncologic patients or HSCT patients will die compared to the non-treatment prior to chemotherapy strategy...
  16. ncbi request reprint Possible association between diabetes and bisphosphonate-related jaw osteonecrosis
    Mogher Khamaisi
    Department of Internal Medicine B and the Diabetes Center, Hebrew University Hadassah Medical Center, Kiryat Hadassah, P O Box 12000, Jerusalem 91120, Israel
    J Clin Endocrinol Metab 92:1172-5. 2007
    ..Bisphosphonate-related osteonecrosis (BON) of the jaws is a newly identified condition for which the exact mechanism involved in its pathogenesis remains obscure...
  17. doi request reprint A systematic review of viral infections associated with oral involvement in cancer patients: a spotlight on Herpesviridea
    Sharon Elad
    Department of Oral Medicine, Hebrew University, Hadassah School of Dental Medicine, Jerusalem, Israel
    Support Care Cancer 18:993-1006. 2010
    ..Quality of life (QOL) and economic impact were assessed if available in the articles reviewed...
  18. doi request reprint Exceptional oral manifestations of amyloid light chain protein (AL) systemic amyloidosis
    Sharon Elad
    Department of Oral Medicine, Hebrew University Hadassah School of Dental Medicine, Jerusalem, Israel
    Amyloid 17:27-31. 2010
    ..Since these oral manifestations can contribute to the diagnosis of systemic amyloidosis, clinicians should be made aware of them. Future research should assess the significance of oral manifestation as a prognostic indicator...
  19. doi request reprint Post-autologous stem cell transplantation administration of rituximab improves the outcome of patients with aggressive B cell non-Hodgkin's lymphoma
    Panagiotis Tsirigotis
    Department of Bone Marrow Transplantation and Cancer Immunotherapy, Hadassah Hebrew University Medical Center, P O Box 12000, Jerusalem 91120, Israel
    Ann Hematol 89:263-72. 2010
    ..We consider that the results of our study are promising but need to be verified within large randomized trials...
  20. doi request reprint Cytotoxic chemotherapy-induced odontalgia: a differential diagnosis for dental pain
    Yehuda Zadik
    Department of Oral Medicine, Hebrew University Hadassah School of Dental Medicine, Jerusalem, Israel
    J Endod 36:1588-92. 2010
    ..Currently, localized pulpal pain is not listed as a possible complication of cytotoxic therapy. The aim of this report was to suggest cytotoxic-induced neurotoxicity as a differential diagnosis for toothache during anti-cancer therapy...
  21. ncbi request reprint A new management approach for dental treatment after a cerebrovascular event: a comparative retrospective study
    Sharon Elad
    Department of Oral Medicine, Hebrew University Hadassah School of Dental Medicine, Jerusalem, Israel
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod 110:145-50. 2010
    ..The purpose of this study was to suggest that the importance of dental care during this period exceeds the risk of medical complications in this patient population...
  22. doi request reprint Bisphosphonate-related osteonecrosis of the jaw: clinical correlations with computerized tomography presentation
    Sharon Elad
    Department of Oral Medicine, Hebrew University Hadassah School of Dental Medicine, Jerusalem, Israel
    Clin Oral Investig 14:43-50. 2010
    ..A large lesion on CT should raise the index of suspicion for sequestrum. The CT appearance of a continuous cortex of the mandibular canal may serve as a differential parameter between BRONJ and metastasis to the jaw...
  23. ncbi request reprint Oral effects of nonmyeloablative stem cell transplantation: a prospective observational study
    Sharon Elad
    Deparment of Medicine, Hebrew University Hadassah School of Dental Medicine, Jerusalem, Israel
    Quintessence Int 39:673-8. 2008
    ..The goal of the study was to evaluate the oral mucosal effects, including oral acute graft versus host disease (aGVHD), in patients undergoing NST in comparison to patients undergoing myeloablative HSCT...
  24. ncbi request reprint Successful transplantation of haploidentically mismatched peripheral blood stem cells using CD133+-purified stem cells
    Menachem Bitan
    Department of Bone Marrow Transplantation and Cancer Immunotherapy, Hadassah University Hospital, Jerusalem 91120, Israel
    Exp Hematol 33:713-8. 2005
    ..We report five cases of successful application of immunomagnetic separation of CD133+ stem cells for haploidentically mismatched allogeneic stem cell transplantation...
  25. doi request reprint Dentists' knowledge and implementation of the 2007 American Heart Association guidelines for prevention of infective endocarditis
    Yehuda Zadik
    Department of Oral Medicine, Hebrew University Hadassah School of Dental Medicine, Jerusalem, Israel
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod 106:e16-9. 2008
    ..Our aim was to evaluate the knowledge and implementations of the 2007 American Heart Association guidelines for the prevention of infective endocarditis (IE) among practicing Israeli dentists, 12 months after their publication...